Phase 1 Graft vs Host Disease Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Graft vs Host Disease

National Cancer Institute (NCI)50 enrolled2 locationsNCT05531786

Recruiting

Phase 1

Chimeric Natural Killer Receptor-Universal T Cells for Refractory GVHD

Graft vs Host Disease

Fujian Medical University17 enrolled1 locationNCT06568328